TGIF! 😍 As we head into the weekend, here's some weekly highlights:

☑️ TONS of interviews from #AACR24 & #ASPHO24 with Claudio Cerchione, Shaikha Alqahtani MD, Eddie Cliff, & more

☑️ New HemOnc Pulse episode with chadi nabhan MD, MBA, FACP & Jamile Shammo, MD

Don't miss it! buff.ly/3qWub18

At #AACR24 , Eddie Cliff, of Harvard Medical School, shared an updated analysis of agents that were approved via the U.S. FDA Accelerated Approval Program over the last 10 years.

📺 Watch the interview here! buff.ly/3xzwyKQ

FDA Oncology AACR

Ken Anderson, MD, of Dana-Farber, discusses the 'revolution' in #myeloma therapies at #AACR24 !

Watch here: buff.ly/43T35aO

See below the interview as I provide a summary on our research for cladribine use in pediatric leukemia conducted under the supervision David McCall. #MedEd #endcancer #Leukemia MD Anderson Cancer Center

At #ASPHO24 , Shaikha Alqahtani MD, of MD Anderson Cancer Center, gave a rundown of the safety and efficacy of cladribine in pediatric relapsed leukemias.

Watch the full interview here to learn more about her study! buff.ly/3vDLwyV

The latest #HemOnc Pulse podcast is out with Dr. Shammo (not on X) from Lurie Cancer Center Northwestern Medicine joining me to talk #MDS (myelodysplasia.) what's new to assess prognosis and how best to select therapy. Blood Cancers Today

Pls subscribe, rate, & share.

bloodcancerstoday.com/podcast/hmas-a…

🤔 Is there a lack of consistency among patient-reported outcome measures used to evaluate treatments for CML?

📋 A study presented by a team from Medical College of Wisconsin at #NCCN2024 addressed the question.

➡️ Learn more: buff.ly/43SaXsS

🚨 Out now! 🚨

On this week's episode of “The HemOnc Pulse,” Jamile Shammo, MD, of Northwestern, joins host chadi nabhan MD, MBA, FACP to discuss how to approach treatment for #MDS , including treating patients with ESAs or HMAs.

🎧 Listen here! buff.ly/4aOvGjQ

It was a pleasure to cover news at #AACR24 ! Thank you to the AACR team: Rick Buck, Julie Gunther, Julia Demalto (and anyone we may have forgotten!) for being so accommodating, from providing us with meals to booking interview rooms. See you next year in Chicago!

The future is bright for NK cell therapy with so many innovative products and scientific discoveries in the pipeline 🤩! Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center #NK #Engineering #CAR

Dr. Claudio Cerchione (Claudio Cerchione), of IRST "Dino Amadori" IRCCS, shares his expert perspective on the potential of emavusertib plus azacitidine and venetoclax in patients with AML in complete response with MRD, as presented at #AACR24 !

📺 Watch here: buff.ly/4aOazOx

Today's the last day of #AACR24 ! Antonio Carlos

Check out our on-site video interviews to keep up to date on all things hematologic oncology 😊

What was your favorite part of the conference?

➡️ buff.ly/43Z9xgn

Paolo Ghia, MD, PhD, of Università Vita-Salute San Raffaele, talks about his session on monoclonal B-cell lymphocytosis at #AACR24 ! AACR

📺 Watch here: buff.ly/4cOXpT4